FDA Drug Application (205777) for TARGINIQ by PURDUE PHARMA LP

Back to FDA Applications sponsored by PURDUE PHARMA LP

Application Number205777
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage5MG;10MG
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameTARGINIQ
Active IngredientNALOXONE HYDROCHLORIDE; OXYCODONE HYDROCHLORIDE



Back to FDA Applications sponsored by PURDUE PHARMA LP

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.